-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Initiates Coverage On Tango Therapeutics with Overweight Rating, Announces Price Target of $46

Benzinga·07/15/2026 10:40:03
Listen to the news
JP Morgan analyst Brian Cheng initiates coverage on Tango Therapeutics (NASDAQ:TNGX) with a Overweight rating and announces Price Target of $46.